Customer Stories
We are living in an age of rapid scientific discovery, generating ever more detailed insights into the building blocks of life – DNA, RNA and proteins. These advances are improving our everyday lives, changing the way people are treated for illnesses like cancer, tuberculosis and genetic disease, helping to find new medicines and even safeguarding the public. Our customers are the heroes stepping up to the challenge of unlocking answers and driving these discoveries. Explore a wide range of customer stories and videos on their scientific breakthroughs and healthcare advances below.
-
Infectious Disease | NeuMoDxShifting gears in clinical testing
At the beginning of the COVID-19 pandemic, the first lab in Michigan to run PCR tests processed about 90 samples a day. By the time Omicron hit, it processed 2,700. But how did the they manage keep up with testing needs? Especially when the nation faced massive shortages in testing kits? -
dPCRTesting sewage to halt a pandemic
While scientists have broken all records to find a vaccine and medical staff have put themselves at risk on the pandemic's frontline, early-warning surveillance is needed to help authorities continue to fight COVID-19 and even prepare for future outbreaks. This is where wastewater testing comes in. -
Infectious Disease | QIAstat-DxOutrunning viruses with molecular tools
Clinical virologist, Dr. Allison Glass, thrives on fast-paced results, whether she’s running an ultramarathon or running a state-of-the-art molecular testing lab. But what is most fascinating to her, are the multitude of viruses out there and how an entity that can’t even carry out its own life cycle can cause so much destruction. -
MicrobiomeWhat can Arctic microbes tell us about climate change?
Microbial ecologist, Stefan Thiele, travels to the most remote areas of the Arctic to study microbial communities in the ice. But what can these microbes tell us about climate change, now and in the future? -
Infectious DiseaseWhy continued COVID-19 testing matters
As the nature of the pandemic has changed, and with promising COVID-19 treatments becoming available – it is difficult to decide when and how to use the different kinds of test available. How are labs deciding how to test? And why is continued testing so important? -
Sample Prep | DNA KitsIdentifying the world’s rarest coral
How we can genetically identify weaker corals before they die? One marine biologist is on mission to find out why some corals are more resilient to changes in our environment than others - At a cellular level. -
HID | NGSSolving abandoned cold cases with molecular testing
A forensics lab overcomes the challenges of obtaining high quality DNA from ancient remains often associated with cold cases. -
Infectious Disease | TuberculosisFighting the stigma. The key to eliminating TB.
Tuberculosis survivor and mycobacteriosis specialist uses QIAreach QuantiFERON-TB to test, treat and educate remote communities vulnerable to TB. -
dPCRGuiding researchers with cutting edge dPCR technology
Clinical researchers are on a quest for medical breakthroughs. And fast. BioXpedia, a supporting lab is using digital PCR, the QIAcuity, to ensure accurate data from the unique samples they are given. -
Infectious Disease | TB ManagementFighting TB: Two countries, one disease, one solution
Tuberculosis does not discriminate. Two committed scientists separated by one vast ocean rely on molecular testing to quickly and automatically detect latent TB before it spreads to others in their communities. -
CRISPRThe future of gene doping and how to test for it
The evolution of Gene-doping, a new method of enhancing performance amongst athletes, and how one can test for it using PCR techniques. -
Informatics & Data | QDITargeting the Achilles’ heel of tumors using molecular pathways
Not every cancer reacts the same way to a treatment. So why target all cells indiscriminately? -
Syndromic Testing | QIAstat-DxKeeping thousands of passengers safe in floating cities
How do you ensure passenger safety on an enclosed ship? Especially when they number in the thousands. Costa Cruises has found a way. -
Genomics | QIAseq NGS SolutionsSequencing COVID-19 mutations after jumping species
First there was a mink-associated COVID-19 strain outbreak. Then several countries reported variants in household pets. But Denmark had a plan to combat these potential vaccine escape mutants. -
Infectious Disease | TuberculosisHelping migrants start a new life without TB
Dr. Christian Herzmann, an expert in respiratory disease, is exploring creative ways to connect with a community susceptible to TB. -
Infectious Disease I NeuMoDxMolecular testing in travel medicine
When lockdown began to ease in the UK, the creatives were on the front line to get back to work. But how can you test the hundreds of individuals that make up a film crew? -
Sample Prep | DNA KitsIdentifying bizarre samples using DNA sequencing data
Sequencing expert, Claire Griffin, continues to find new ways to identify the stranger side of nature by extracting DNA from bizarre tissue samples. -
PCRDetecting microbial contamination
Microbiology lab built from the ground up using QIAGEN PCR technology to ensure valid results, cell line detection, and no contamination. -
dPCRHow oysters led to COVID-19 testing
I.A.G.E. analyze wastewater samples for COVID-19 through digital PCR (QIAcuity) to monitor outbreaks and target specific sequences identifying SARS-CoV-2 mutations. -
Infectious Disease | TuberculosisTreating latent TB in rural China
Fighting tuberculosis in rural china, with the third most cases of the infection worldwide, through testing and prevention. -
Infectious Disease | TuberculosisEradicating tuberculosis in hotspot regions
TB’s impact is global, and can be transmitted to anyone around the world, rich or poor. But how are healthcare authorities in different hotspot regions combatting the disease? -
Syndromic testing | QIAstat-DxQuick pivot enables lab to serve community during pandemic
Great Lakes Labs president and CEO Michelle Volk redirected her lab’s focus from forensics to clinical medicine in reaction to the COVID-19 pandemic to provide her community with rapid, accurate testing, and peace of mind. -
Genomics | QIAseq NGS SolutionsFaster cancer diagnoses using Artificial Intelligence
Japanese startup, PFDeNA, uses deep learning to quickly and accurately detect and diagnose different cancer types. -
Sample Technology I QIAsymphony & DNA kitsUsing bacterial signatures to screen for colorectal cancers
The team at GoodGut develop an uninstructive alternative to current colorectal cancer diagnostic methods (which can often result in complications) using gut bacteria. -
Diagnostics & Clinical Research | therascreenTreatments for patients on day one
NeoGenomics, the U.S.’s largest cancer diagnostic company set a precedent for the future of diagnostics by delivering a novel treatment to breast cancer patients on day one. -
Sample Prep | DNA ExtractionSaving biodiversity through DNA barcoding
Dr. Fontanilla guides conservation efforts to turn the tide on mass extinction and illegal wildlife trade using through DNA barcoding. -
dPCRIdentifying the genetics behind obesity using dPCR
Digital PCR technology determines exact copy numbers from a single gene explaining why some individuals are prone to obesity. -
Microbiome | DNA KitsUsing the human microbiome to decipher crime scene traces
Forensic investigators analyze genomes of human microorganisms to determine what took place at a crime scene. -
Syndromic testing | QIAstat-DxAvoiding repeat hospital visits with syndromic testing
The team at Mako Medical ensure fast test results to vulnerable senior communities, knowing that delays can present a real dilemma for patients with little time for diagnoses. -
Infectious Disease | TuberculosisBattling tuberculosis in the time of COVID-19
Dr. Story brings tuberculosis testing and treatment to susceptible homeless communities knowing that a disruption in TB testing during COVID would have major consequences. -
PCR | Digital PCRdPCR. Standardized diagnostics from London to Shanghai.
Dr. Jim Huggett is using digital PCR to overcome one of the biggest challenges in diagnostics: how to standardize tests globally. -
About QIAGEN I Digital TransformationThe digital mindset is part of our DNA
A team in Poland is transforming QIAGEN in the age of digitization. -
Infectious Disease | COVID-19Achieving production goals in record time
Maine company pushes the limit and does the impossible to design a spin column machine in record time to help in testing for coronavirus. -
Infectious Disease | COVID-19Suppliers behind the front lines of COVID-19Suppliers are finding novel solutions to help diagnostic companies like QIAGEN ramp up production to provide urgently needed COVID-19 testing materials. -
HID & Forensics | Investigator SolutionsDeciphering RNA to solve impossible crime scenes
Forensic scientists are finding answers to almost impossible human ID cases with degraded and challenges samples through the help of RNA. -
Infectious Disease | COVID-19Ensuring critical deliveries when every minute countsUPS teams up with QIAGEN to deliver coronavirus testing solutions to curb the SARS-CoV-2 pandemic. -
Microbiome | DNA KitsAir microbiome provides answers to climate change
London researcher sequences invisible microbiome in air to understand why and how this ecosystem evolves. -
TB Management l QuantiFERONTuberculosis diagnosis turns patients into advocates
A trip to Africa set a couples’ life on a course they will never forget after contracting the world’s deadliest infectious disease. -
BioinformaticsAnalyzing the ancient origins of rare genetic diseases
Pushing the limits of genetic research in the study of rare disease in Turkey. -
Sample Prep | RNeasy KitRecovering RNA from miniscule samples
Using QIAGEN’s RNeasy Kit to purify quality RNA from colonic biopsies gaining insights to combat inflammatory bowel disease (IBD). -
TB Management | QuantiFERONTesting millions to stop tuberculosis migration
Why labor migration is an important factor in fighting against the world's deadliest infectious disease. -
NGSThe dawn of a new age
Professor Paul Hofman uses next-generation sequencing to gain unparalleled insights in oncology. -
NGSInterview Prof. Paul Hofman
Interview with Professor Paul Hofman as he explains the challenges in pathology and new approaches in the field using NGS. -
MicrobiomeBehavior - it's all in our gut
Interview with Dr. Michael Montague on how the gut microbiome of free-ranging primates shapes their social interactions and vice versa. -
TuberculosisOur goal is to develop easy and quick tests
Interview with Dr. Delia Goletti in her fight against tuberculosis at Italy’s National Institute for Infectious Disease. -
TuberculosisFighting a common and persistent killer
The rise of multi-resistant strains of the most common chronic global infection demands new approaches in fighting the disease. -
NGSSingapore showcase
Dr. Liu Jianjun plans on sequencing the genome of 10,000 Singaporeans in an effort to revolutionize medical science using Big Data. -
Infectious DiseasesBattling infectious diseases
Geneva-based non-profit FIND, combats widespread poverty-related diseases with collaborative approaches to defeat new epidemic threats. -
Life Science ResearchMans best friend
Dr. Tomas Bergström and his team are carrying out groundbreaking genetic research on dogs that has huge potential benefits for human health. -
MicrobiomeMapping a hidden world
Scientists around the world embark on an ambitious project to chart and better understand the microbiome on every surface. -
AUTOMATIONDiverse appeal
Four experts in four countries. What do their laboratories have in common? The QIAsymphony system. -
NGSA promising future
Interview with Dr. Richard K. Wilson, of the Children’s Hospital in Columbus, on the advances in genomic science. -
TuberculosisLike a smoldering ember that can catch fire again
How the leading TB assay can help tackle Japan’s high infection rates and the world’s top infectious disease killer. -
HID & ForensicsLooking to the future of missing persons analysis with NGS
The International Commission on Missing Persons collaborates with QIAGEN in becoming the leader in human identity testing. -
CSRSupport and challenge
Integrating qualified refugees into the local labor market of western societies to strengthen our communities. -
Life Science ResearchCracking the code - how RNA may hold the answer
Geneticists try to unravel the mysteries of RNA as it plays a vital role in regulating normal physiology. -
HID & ForensicsNames for the dead certainty for the survivors
The largest-ever DNA identification project is underway to name those who perished more than 40 years ago in the Vietnam War. -
Cancer researchBetween two worlds
Interview with leading pathologist Dr. Soonmyung Paik discussing the development and use of genetic testing in cancer patient treatments. -
Infectious DiseasesBeating healthcare-associated infections
Controlling healthcare-associated infections with advanced molecular tests and preventive screening. -
AUTOMATIONAutomating diagnostics for the future
Herlev hospital meets new demands in patient care by enhancing their workflow through automation. -
Cancer ResearchBreaking the code - companion diagnostics
The benefits of companion diagnostics become clear at the Queen Elizabeth Hospital in Birmingham, England. -
Bioinformatics | IPANeutralizing a bio-terrorist threat
Unraveling the mysterious pathways of a biodefense pathogen using IPA in the search for a therapeutic against dangerous arboviruses. -
COVID-19Latest newsLatest news on QIAGEN efforts to support healthcare workers in controlling the coronavirus (COVID-19) outbreak – now a pandemic. -
Microbiome | DNA kitsGut microbiomes as a cancer therapy
Specific bacteria within human microbiomes are utilized to lower side effects that come with oncological patient care. -
Infectious DiseaseA new frontier for PCR testing
The NeuMoDx 288 Molecular System is tested in one of the largest medical labs in Eastern Germany. -
NGSThe immune system as medicine
Immune cells are manipulated to defend against cancer using QIAGEN’s next-generation sequencing technologies. -
HID & ForensicsExplosive discoveries from trace DNA
Extracting seemingly impossible information from highly degraded touch DNA left on explosives and firearms with QIAGEN’s DNA extraction kits. -
NGSOn the brink of a breakthrough
Solving the mystery of an extremely high incidence of lung cancer in Northern Thailand with QIAGEN´s GeneReader NGS System. -
GenomicsAttacking cancer from all angles
How QIAseq FastSelect helps pave the way towards more successful cancer treatment. -
TB ManagementMaking an impact in Africa
A task with a mission: helping the thousands of refugees and migrants dependent on fast and accurate latent TB results. -
GenomicsDiabetes linked to arsenic
Discovering the connection between environmental arsenic exposure and type II diabetes with QIAGEN Genomic Services. -
TB ManagementFighting the unknown
How a mystery ailment rattled a teacher and hundreds of students in Vermont. -
HID & ForensicsBringing closure to families
A new NGS workflow allows identification of missing persons from the most difficult samples. -
Infectious Diseases | QIAstat-DxInfluenza or something else
A new syndromic testing device, the QIAstat-Dx is cutting costs and saving time in the emergency room.